Buprenorphine treatment produces greatest health gains and cost savings for mothers and infants

Buprenorphine treatment produces greatest health gains and cost savings for mothers and infants

Over the last 20 years, substance use-related deaths have more than doubled for women of reproductive age. Overdose deaths are now a leading cause of maternal mortality in the U.S., and in some states, the leading cause. Still, substantial gaps remain in understanding how different treatment approaches influence the short- and long-term health of mothers…

Read More